Develops and markets the VasQ™ extravascular support device to improve AV fistula maturation in hemodialysis

Laminate Medical Technologies Ltd.

Tel Aviv, Israel · Berlin, Germany · New York, USANew on Amplifa

2012Founded

11-50 employees (27 according to IVC)Employees

3 locations (Tel Aviv, Berlin, New York)Locations

About Laminate Medical Technologies

Laminate Medical Technologies was founded in 2012 by Tammy Gilon and Dr. Eyal Orion and develops solutions to improve the function of arteriovenous fistulas (AVF) for hemodialysis patients. Its flagship product is the VasQ™ External Support, an extravascular support device implanted during surgical fistula creation. It permanently reinforces the anastomosis, stabilizes the vessel wall against wall tension and reduces turbulent flow in order to improve fistula maturation and reduce reinterventions. Clinical studies, including a randomized controlled trial published in 2020 in the American Journal of Kidney Diseases, show a significantly higher probability of successful fistula maturation without additional interventions. The company holds CE marking for VasQ, has locations in Tel Aviv, Berlin and New York, and supplies medical facilities in Israel, Europe, the USA and Asia-Pacific. Business areas include, in addition to device sales, clinical trial support and market access for dialysis access.

Site: 21 Tel Aviv
Processes: Extravascular support device (VasQ) to improve AV fistula maturation, Clinical trial support, Sales and market access for dialysis access
Certificates: CE marking, CE marking (VasQ)
Founded: 2012
Employees: 11-50
Industries: Medical technology, Hemodialysis, Vascular access, Nephrology

01
Product development (engineering & design)
02
In-house and external manufacturing (manufacturing, subcontractor manufacturing)
03
Supply chain management (MRP, procurement, sales operations)
04
Clinical development and study support
05
Sales and market access

Locations

Tel Aviv, Israel

Headquarters

Berlin, Germany

Branch office (Europaplatz 2)

New York, USA

US office (101 Avenue of the Americas, 9th Floor)

Components & Products

**VasQ™ extravascular support device**Medical device · hemodialysis / vascular access

Industries

Medical technologyHemodialysisVascular accessNephrology

Additional services

Extravascular support device (VasQ) to improve AV fistula maturationClinical trial supportSales and market access for dialysis access

Reference customers

Ochsner Health (New Orleans, first user in Louisiana as part of a post-market study)

Quality & Approvals

VasQ is CE marked; the clinical efficacy was investigated in a randomized controlled trial published in 2020.

Evidence	Tel Aviv, Israel
CE marking (VasQ)

History

2012
Laminate Medical Technologies founded by Tammy Gilon and Dr. Eyal Orion
2015
Ran Agam joins as VP Operations & Engineering
2020
Randomized controlled trial on VasQ published in the American Journal of Kidney Diseases (Karydis et al.)
2024
Galit Itzhaki joins the company as VP Clinical Development
2026
Ochsner Health (New Orleans) implants VasQ for the first time in Louisiana as part of a randomized prospective study